C. Comisar

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.

B. Frederick, Honghui Zhou, E. Bouman-Thio, 2011, British journal of clinical pharmacology.

Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies

P. Chang, F. Bellanti, B. Bartok, 2021, British journal of clinical pharmacology.

Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer

E. Cox, K. Vishwanathan, H. Witjes, 2017, British journal of clinical pharmacology.

The benzil-benzilic acid rearrangement in high-temperature water

P. Savage, C. Comisar, 2005 .

Effect of pH on Ether, Ester, and Carbonate Hydrolysis in High-Temperature Water

Phillip E. Savage, P. Savage, Shawn E. Hunter, 2008 .

Kinetics of crossed aldol condensations in high-temperature water

P. Savage, C. Comisar, 2004 .

Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups

James G. Wright, Diansong Zhou, T. Riccobene, 2018, Clinical and translational science.

Fuel cell performance and characterization of 1-D carbon-supported platinum nanocomposites synthesized in supercritical fluids

André D. Taylor, R. Sekol, Jeremy Kizuka, 2008 .

Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects.

Y. Tsukamoto, Honghui Zhou, Zhenhua Xu, 2013, International journal of clinical pharmacology and therapeutics.